Pfizer(US:PFE) Xin Lang Cai Jing·2025-12-17 06:20Core Insights - Pfizer Inc. has had its application for Sulfate Remegipant orally disintegrating tablets accepted by the National Medical Products Administration on December 17, 2025 [1] Company Overview - Pfizer Inc. was established on October 7, 1989, and is classified as a medium-sized foreign-owned limited liability company in the chemical pharmaceutical manufacturing industry [1] - The company has a registered capital of 80.4 million USD and a paid-in capital of 80.4 million USD, with 935 insured employees [1] - The sole shareholder is American Hui Zhi Enterprise Company, holding 100% of the shares with a subscribed capital contribution of 80.4 million USD, dated November 30, 2017 [1] Application Details - The application number for the drug is JXHB2500169, categorized as a chemical drug under a supplementary application with a registration classification of 2.4 [1] - The application was officially accepted on December 17, 2025 [1]